Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE2
1200 participants
INTERVENTIONAL
2023-06-12
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tobacco Intervention in Primary Care Treatment Opportunities for Providers
NCT02096029
Take A Break - Rural
NCT05790486
Effective Ads for Quitting Smoking
NCT06485479
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
NCT00218296
Nicotine Lozenge to Reduce Smokeless Tobacco Use
NCT00218283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electric Toothbrush
Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and an electric toothbrush.
Ask-Advise-Refer
All patients will be asked if they smoke, advised to quit, and referred to the state quitline
Nicotine Replacement Therapy
Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and a two week supply of 14mg nicotine patches and 4mg lozenges.
Ask-Advise-Refer
All patients will be asked if they smoke, advised to quit, and referred to the state quitline
Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release
14 mg transdermal nicotine patch
Nicotine lozenge
4mg nicotine lozenge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ask-Advise-Refer
All patients will be asked if they smoke, advised to quit, and referred to the state quitline
Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release
14 mg transdermal nicotine patch
Nicotine lozenge
4mg nicotine lozenge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* smokes at least 1 combustible cigarette per day on at least 25 days of the month
Exclusion Criteria
* myocardial infarction or stroke in the past 3 months
* pregnant or breastfeeding
* use of tobacco cessation medication in the past week
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Massachusetts General Hospital
OTHER
Northwestern University
OTHER
HealthPartners Institute
OTHER
University of Alabama at Birmingham
OTHER
Kaiser Permanente
OTHER
University of Rochester
OTHER
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Hennepin Healthcare Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra Japuntich
Role: PRINCIPAL_INVESTIGATOR
Hennepin Healthcare/University of Minnesota Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fang P, Adkins-Hempel M, Lischka T, Basile S, Rindal DB, Carpenter MJ, Kopycka-Kedzierawski DT, Dahne J, Helseth SA, Levy DE, Truong A, Leo MC, Funkhouser K, Louis DR, Japuntich SJ; National Dental PBRN Collaborative group. A National Dental Practice-Based Research Network phase II, cluster-randomized clinical trial assessing nicotine replacement therapy sampling in dental settings: study protocol for the Free Samples for Health (FreSH) study. BMC Oral Health. 2024 Aug 28;24(1):1007. doi: 10.1186/s12903-024-04758-w.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.